1[1]Diaz MO, Rubin CM, Harden A, et al. Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med, 1990, 322(2): 77
2[2]James CD, He J, Collins VP, et al. Localization of chromosome 9p homozygous in glioma cell lines with markers constituting a continuous linkage group. Cancer Res, 1993, 53(16): 3674
3[3]Cheng Jinquan, Jhanwar SC, Lu Youyong, et al. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res, 1993, 53(20): 4761
4[4]Kamb A, Gruis N, Weaner-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994,15(264): 436
5[5]Noborl T, Miura K, Wu DJ, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994,368(6473): 753
6[6]Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 1995, 88 (3): 841
7[7]Serrano M, Hannon GT, Beach D. A new regulation motif in cell cycle control causing special inhibition of cyclinD/CDK4. Nature,1993, 366(6456): 704
8[8]Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin function in yeast. Cell, 1991,66(165):1197
9[9]Yang Rong, Gombart AF, Serrano M, et al. Mutational effects on the p16INK4a tumor suppression protein. Cancer Res, 1995, 55(15):2503
10[10]Li Yan, Nichols MA, Shay JW, et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res, 1994,54(23):6078
